Table 1.
Upregulated miRNAs.
miRNAs | Targets | Biological outcome | Models | References |
---|---|---|---|---|
miR-192 | δEF1, SIP1 | COL1α1 and COL1α2 ↑ | Diabetic mice (STZ), db/db mice | [24] |
ZEB1/2 | TGF-β, Col, FN ↑, proteinuria ↓ | Diabetic mice (STZ) | [22] | |
| ||||
miR-216a | PTEN, YBX1 | MMC survival, hypertrophy, COL1α2 ↑ | MMCs | [28, 29] |
| ||||
miR-217 | PTEN | MMC survival, hypertrophy | MMCs | [28] |
| ||||
miR-200b/c | ZEB1 | TGF-β1, COL1α2, COL4α1 ↑ | Diabetic mice (STZ), db/db mice, MMCs | [22] |
FOG | p-Akt, ERK ↑, hypertrophy | Diabetic mice (STZ), MMCs | [30] | |
| ||||
miR-21 | PTEN, PRAS40 | p-Akt, mTORC1, hypertrophy, COL1α2, FN ↑ | HMCs | [23] |
SMAD7 | Microalbuminuria, TGF-β, NF-κB ↑ | db/db mice | [34] | |
TIMP3 | TIMP3 ↓ | Diabetic mice (STZ), MMCs, kidney biopsy (human) | [35] | |
TIMP1 | COL4, FN, ACR ↑; CCR ↓ | kk-ay mice | [37] | |
| ||||
miR-377 | PAK1, SOD | FN ↑ | Diabetic mice (STZ), MMCs, HMCs | [38] |
| ||||
miR-195 | BCL2 | Caspase-3, caspase-8 ↑ | Diabetic mice (STZ), podocytes, MMCs | [42, 43] |
| ||||
miR-215 | CTNNBIP1 | β-Catenin, FN, α-SMA ↑ | [49] | |
| ||||
miR-124 | INTEGRINα3β1 | Urinary podocyte nephrin, podocin, albumin ↑ | Diabetic rats (STZ) | [51] |
| ||||
miR-29c | SPRY1 | Albuminuria, ECM ↑ | db/db mice | [59] |
| ||||
miR-1207-5p | TGF-β1, PAI-1, FN ↑ | HK-2 cells, podocytes, normal mesangial cells | [52] | |
| ||||
miR-135a | TRPC1 | Microalbuminuria ↑, renal fibrosis ↑ | db/db mice | [53] |
STZ: streptozotocin; δEF1: deltaEF1 (ZEB1); FOG: Friend of GATA; SIP1: Smad-interacting protein 1; Col: collagen; ZEB1/2: zinc finger E-box binding homeobox 1/2; YBX1: Y box binding protein 1; α-SMA: alpha smooth muscle actin; PTEN: phosphatase and tensin homolog; p-Akt: phosphorylated protein kinase B; PRAS40: proline-rich Akt substrate 40; mTORC1: mechanistic target of rapamycin complex 1; SMAD3: mothers against decapentaplegic homolog 3; SMAD7: mothers against decapentaplegic homolog 7; TIMP: tissue inhibitors of metalloproteinase; PAK1: p21 activated kinase; SOD: superoxide dismutase; BCL2: B-cell CLL/lymphoma 2; INTEGRINα3β1: integrin alpha 3 beta 1; SPRY1: Sprouty homolog 1; NF-κB: nuclear factor kappa B; TGF-β: transforming growth factor beta; ERK: extracellular signal-regulated kinases; ECM: extracellular matrix; FN: fibronectin; PAI-1: plasminogen activator inhibitor-1; MMC: mouse mesangial cell; HMC: human mesangial cell; RMC: rat mesangial cell; ACR: albumin creatinine ratio; CCR: creatinine clearance ratio; TRPC1: transient receptor potential cation channel, subfamily C, member 1.